4.6 Article

Glycan structure of Gc Protein-derived Macrophage Activating Factor as revealed by mass spectrometry

Journal

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Volume 606, Issue -, Pages 167-179

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.abb.2016.08.006

Keywords

Vitamin D binding protein; GcMAF; Linear trisaccharide; Disaccharide; ESI-MS; Linkage analysis

Ask authors/readers for more resources

Disagreement exists regarding the O-glycan structure attached to human vitamin D binding protein (DBP). Previously reported evidence indicated that the O-glycan of the Gc1S allele product is the linear core 1 NeuNAc-Gal-GalNAc-Thr trisaccharide. Here, glycan structural evidence is provided from glycan linkage analysis and over 30 serial glycosidase-digestion experiments which were followed by analysis of the intact protein by electrospray ionization mass spectrometry (ESI-MS). Results demonstrate that the O-glycan from the Gc1F protein is the same linear trisaccharide found on the Gc1S protein and that the hexose residue is galactose. In addition, the putative anti-cancer derivative of DBP known as Gc Protein derived Macrophage Activating Factor (GcMAF, which is formed by the combined action of beta-galactosidase and neuraminidase upon DBP) was analyzed intact by ESI-MS, revealing that the activating E. coil beta-galactosidase cleaves nothing from the protein leaving the glycan structure of active GcMAF as a Gal-GaINAc-Thr disaccharide, regardless of the order in which I3-galactosidase and neuraminidase are applied. Moreover, glycosidase digestion results show that alpha-N-Acetylgalactosamindase (nagalase) lacks endoglycosidic function and only cleaves the DBP O-glycan once it has been trimmed down to a GaINAc-Thr monosaccharide precluding the possibility of this enzyme removing the O-glycan trisaccharide from cancer-patient DBP in vivo. (C) 2016 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available